Aileen Eiszele Email & Phone Number

Perth, Western Australia, Australia

Buidling and maintaining relationships to foster growth and enhance service delivery across two private comprehensive cancer centres.

Www.Aandlmedcom.Com

A & L Medical Communications is a specialised medical writing and translations small business which aims to assist non-native English speakers and busy researchers to publish their work in the leading international journals. Services include, but are not limited to:- Medical writing, proofreading and editing of manuscripts - Preparation of slide presentations or posters for conferences- Content and key message development for the pharmaceutical industry- Translations: FR/DE/EN

Perth, Australia

- Responsible for marketing and referrer engagement activities across five oncology centres in Western Australia.- Developed initial promotional materials from a virtually zero base to increase awareness of service provision.- Manager to two representatives- Key activities: Launch of new treatment centres and radiation treatment techniques (e.g. skin, SABR, deep inspiration breath hold), external communications including social media, website content & development, specialist newsletters, medical writing, PR/media/press releases, event management, referrer engagement.

Perth, Australia

- Achieved over-target sales in 2014 for Avastin® (bevacizumab) across its indications and successfully launched the product in ovarian cancer. - Achieved over-target sales in 2013 for Herceptin® (trastuzumab) versus the previous year.- Successfully launched Kadcyla® (trastuzmab emtansine) and Perjeta® (pertuzumab) in metastatic breast cancer.

Perth, Australia

- Responsable for the management and sales of Welch Allyn medical devices across the state of Western Australia. - Obtained for the first time contracts at Sir Charles Gairdner Hospital, Albany Hospital, Royal Perth Hospital and Princess Margaret Hospital for Children, which generated additional revenue for the company.

Brussels

Product Manager for Taxotere® (docetaxel) in breast and head & neck cancers across Belgium and Luxembourg.From May, 2010 in addition to Taxotere®: - Product Manager for BSI-201 (iniparib) until it was discontinued in breast cancer. - Product Manager for Fasturtec® (rasburicase). From August 2007 - September 2009 in addition to Taxotere: - Product Manager for Granocyte® (lenograstim) until the product was returned under the contractural agreement to its original manufacturer.Marketing:Responsible for the management of the oncology marketing budget (1.2m euros) and the strategic marketing plan to achieve sales of 26m euros for Taxotere® (docetaxel) in breast and head & neck cancers and 1.0m euros for Fasturtec® (rasburicase).Market Access:Set two precedents for drug reimbursement in Belgium:- Wrote the government submission file and lobbied KOLs which resulted in the reimbursement of the Taxotere®/cyclophosphamide (TC) combination in node-positive adjuvant breast cancer without EU registration - this is the equivalent of listing a drug on the PBS without TGA approval. - Obtained reimbursement for Taxotere® only (and not its generics) in node-negative breast cancer. Product Launches:- Launched the Taxotere® 1-vial and 160 mg presentations- Created the company's first online training and information website for pharmacists, and managed the complicated logistics of phasing in the new presentations while phasing out the 'old'.Actively involved in the development of investigator sponsored trials including the SOLD international study and the national TC trial in early breast cancer patients.Sales force: - Training of six sales representatives. Communications: - Yearly advisory boards; promotional meetings with international key opinion leaders (KOLs)- Development of the media plan and media liaison; creation of sales materials; market research; medical writing/editing and collaborator for EU promotional meetings for the global office in Paris.

Brussels Area, Belgium

Brand Manager for Herceptin® (trastuzumab) in breast cancer.Marketing: - Responsible for the management of the Herceptin® marketing budget and the development of the marketing plan and associated activities to drive growth across Belgium and Luxembourg.Market Access: - Worked with KOLs and pathologists to develop HER2 testing standards across Belgium.- Successfully applied to the government for modification of the Herceptin® reimbursement criteria. Product launch: - Adjuvant breast cancer indication: managed all external and internal communications including local media; organised the national ‘themed’ launch meeting with presentations by internationally recognized speakers from the USA and EU. This attracted the highest number of participants for a meeting of this type at the time in Belgium.Clinical Trials: - Managed the Medical Need Program across Belgium and initiated local investigator sponsored trials.Sales Force: - Regularly trained the sales force and created sales materials in line with the marketing plan and communications objectives.

Brussels Area, Belgium

Dual role as Product Manager for Taxotere® (docetaxel) in breast cancer across Belgium and Luxembourg and Key Account Manager for major hospitals in the Brussels region.

Brussels Area, Belgium

Achieved on-target sales of 2.1 million euros for Taxotere® in the treatment of breast and lung cancer, working in French.Liaison with key hospital specialists, meeting organisation, international conference attendance and speaker coordination.

Perth, Western Australia

Achieved over-target sales of $AUD 3.5 million for the oncology product portfolio (Taxotere® and Bonefos®) across the states of Western Australia, South Australia and the Northern Territory.

Sydney, Australia

Marketing: - Responsible for the implementation of all Taxotere® marketing activities in line with the marketing plan.Public Relations and Communications: - Developed the communications strategy for all oncology products: content development for the company’s website; creation of sales brochures and key messages; media liaison and press release writing; medical writing.Event organisation: - Developed the concept of the Aventis Oncology Challenge and solely organised this promotional fundraising event for the NSW Cancer Council with Olympic swimming champions Michael Klim and Geoff Heugill; national product promotional meetings.Clinical trials: - Provided strategic support to the Business Unit Director and obtained medical & regulatory approval

Sydney, Australia

- Achieved over-target sales in excess of $AUD 5.0 million for the oncology product portfolio (Taxotere®, Bonefos® & Anzemet®) in NSW.- Successfully launched Taxotere® in NSCLC & ovarian cancer and worked directly with the Asia-Pacific marketing manager on the ovarian launch campaign.

Sydney, Australia

- Successfully promoted Rocaltrol® (calcitriol) to general practitioners.- Selected for the marketing induction program.- Responsible for in-field training of new representatives.

Perth, Australia

Drove the sales of 8 ethical products, 2 medical devices and 2 over-the-counter products to general practitioners, gynaecologists and pharmacists.Achieved the highest ever reported sales nationally for 2/12 products.

Perth, Western Australia, Australia

French teacher delivering an immersion program from Years 3 - 6 at East Claremont Primary School.

Meekatharra, Western Australia, Australia

Teacher across various subject areas in a remote high school some 750km from Perth.

Hobart, Tasmania, Australia

Year 7 and 8 Japaneses teacher part-time whilst studying at university.

Hobart, Tasmania, Australia

Part-time French teacher across Years 7-12 whilst I was studying at university.

Graduate Diploma Of Business, Marketing, Management

The Graduate Diploma of Business follows the MBA program and requires 8/12 MBA units to be completed. I completed 10/12 MBA units.

Mba Program, Marketing, Cross-Cultural Negotiations, Management

As part of a partnership agreement between Curtin University of Technology (Graduate Business School) MBA program

Certificate Of Marketing And Public Relations

Apma Cep, Pharmacology, Clinical Trials, Ranked In The Top 10 Across Australia

Diploma Of Education, Teaching Diploma: High And Senior High School French And Japanese

Bachelor Of Arts With Honours, French Linguistics

Thesis: 'Le verbe 'prendre' prix au sérieux', published in the Cahiers de Lexicologie, (Paris), No. 62, 1993. Co-authored by Dr Bert.

Bachelor Of Arts, Biology, Zoology, French, Japanese, Political Science, Geography

Recipient of the university academic prize for excellence in the study of French.